The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
Abstract
Purpose: To provide recommendations about prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer. Prophylaxis in the outpatient, inpatient, and perioperative settings was considered, as were treatment and use of anticoagulation as a cancer-directed therapy. Methods: A systematic review of the literature published from December 2007 to December 2012 was completed in MEDLINE and the Cochrane Collaboration Library. An Update Committee reviewed evidence to determine which recommendations required revision. Results: Forty-two publications met eligibility criteria, including 16 systematic reviews and 24 randomized controlled trials. Recommendations: Most hospitalized patients with cancer require thromboprophylaxis throughout hospitalization. Thromboprophylaxis is not routinely recommended for outpatients with cancer. It may be considered for selected high-risk patients. Patients with multiple myeloma receiving antiangiogenesis agents with chemotherapy and/or dexamethasone should receive prophylaxis with either low–molecular weight heparin (LMWH) or low-dose aspirin. Patients undergoing major cancer surgery should receive prophylaxis, starting before surgery and continuing for at least 7 to 10 days. Extending prophylaxis up to 4 weeks should be considered in those with high-risk features. LMWH is recommended for the initial 5 to 10 days of treatment for deep vein thrombosis and pulmonary embolism as well as for long-term (6 months) secondary prophylaxis. Use of novel oral anticoagulants is not currently recommended for patients with malignancy and VTE. Anticoagulation should not be used for cancer treatment in the absence of other indications. Patients with cancer should be periodically assessed for VTE risk. Oncology professionals should provide patient education about the signs and symptoms of VTE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007903 · Cited by 3,237
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
Schulman, S., Kearon, C., Kakkar, A. K., Mismetti, P., Schellong, S., Eriksson, H., Baanstra, D., Schnee, J., & Goldhaber, S. Z. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906598 · Cited by 2,583
Self-citationLee, A. Y. Y., Levine, M. N., Baker, R. I., Bowden, C., Kakkar, A. K., Prins, M., Rickles, F. R., Julian, J. A., Haley, S., Kovacs, M. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025313 · Cited by 2,534
Self-citationBüller (2012) · doi:10.1056/nejmoa1113572 · Cited by 2,353
Development and validation of a predictive model for chemotherapy-associated thrombosis
Khorana, A. A., Kuderer, N. M., Culakova, E., Lyman, G. H., & Francis, C. W. (2008) · Blood · doi:10.1182/blood-2007-10-116327 · Cited by 2,217
Self-citationRisk Factors for Deep Vein Thrombosis and Pulmonary Embolism: A Population-Based Case-Control Study
Heit, J. A., Silverstein, M. D., Mohr, D. N., Petterson, T. M., O'Fallon, W. M., & Melton, L. J. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.809 · Cited by 2,171
Malignancies, prothrombotic mutations, and the risk of venous thrombosis
Blom, J. W. (2005) · JAMA · doi:10.1001/jama.293.6.715 · Cited by 1,949
Horlocker, T. T., Wedel, D. J., Rowlingson, J. C., Enneking, F. K., Kopp, S. L., Benzon, H. T., Brown, D. L., Heit, J. A., Mulroy, M. F., Rosenquist, R. W., et al. (2010) · Regional Anesthesia and Pain Medicine · doi:10.1097/aap.0b013e3181c15c70 · Cited by 1,501
Apixaban for Extended Treatment of Venous Thromboembolism
Agnelli, G., Buller, H. R., Cohen, A., Curto, M., Gallus, A. S., Johnson, M., Porcari, A., Raskob, G. E., & Weitz, J. I. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1207541 · Cited by 1,366 · cited 1×
“1% (5 mg).(58) Additional concerns with using these agents in patients with cancer include: unpredictable absorption and higher risk of GI bleeding in those with mucositis or other GI complications, altered metabolism in those with liver or renal impairment, drug interaction with hormonal and chemotherapeutic agents,…”
BackgroundLyman, G. H., Khorana, A. A., Falanga, A., Clarke-Pearson, D., Flowers, C., Jahanzeb, M., Kakkar, A., Kuderer, N. M., Levine, M. N., Liebman, H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1283 · Cited by 952
Self-citationLevitan, N., Dowlati, A., Remick, S. C., Tahsildar, H. I., Sivinski, L. D., Beyth, R., & Rimm, A. A. (1999) · Medicine · doi:10.1097/00005792-199909000-00001 · Cited by 891
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Palumbo, A., Rajkumar, S. V., Dimopoulos, M. A., Richardson, P. G., San Miguel, J., Barlogie, B., Harousseau, J., Zonder, J. A., Cavo, M., Zangari, M., et al. (2008) · Leukemia · doi:10.1038/sj.leu.2405062 · Cited by 840
Meyer, G., Marjanovic, Z., Valcke, J., Lorcerie, B., Gruel, Y., Solal-Celigny, P., Le Maignan, C., Extra, J. M., Cottu, P., & Farge, D. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.15.1729 · Cited by 796
Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients
Khorana, A. A., Francis, C. W., Culakova, E., Kuderer, N. M., & Lyman, G. H. (2007) · Cancer · doi:10.1002/cncr.23062 · Cited by 781
Self-citationPrediction of venous thromboembolism in cancer patients
Ay, C., Dunkler, D., Marosi, C., Chiriac, A.-L., Vormittag, R., Simanek, R., Quehenberger, P., Zielinski, C., & Pabinger, I. (2010) · Blood · doi:10.1182/blood-2010-02-270116 · Cited by 772
Prevention of Venous Thromboembolism in General Surgical Patients: Results of Meta-analysis
CLAGETT, G. P., & REISCH, J. S. (1988) · Annals of Surgery · doi:10.1097/00000658-198808000-00016 · Cited by 691
Agnelli, G., Bolis, G., Capussotti, L., Scarpa, R. M., Tonelli, F., Bonizzoni, E., Moia, M., Parazzini, F., Rossi, R., Sonaglia, F., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000193959.44677.48 · Cited by 690
A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Method
Bahl, V., Hu, H. M., Henke, P. K., Wakefield, T. W., Campbell, D. A., & Caprini, J. A. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181b7fca6 · Cited by 659
Hull, R. D., Pineo, G. F., Brant, R. F., Mah, A. F., Burke, N., Dear, R., Wong, T., Cook, R., Solymoss, S., Poon, M.-C., et al. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.02.022 · Cited by 607
Agnelli, G., Gussoni, G., Bianchini, C., Verso, M., Mandalà, M., Cavanna, L., Barni, S., Labianca, R., Buzzi, F., Scambia, G., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70232-3 · Cited by 598
Risk of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
Horsted, F., West, J., & Grainge, M. J. (2012) · PLoS Medicine · doi:10.1371/journal.pmed.1001275 · Cited by 565
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Khorana, A. A., & Connolly, G. C. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3271 · Cited by 539
Self-citationSemuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer
Agnelli, G., George, D. J., Kakkar, A. K., Fisher, W., Lassen, M. R., Mismetti, P., Mouret, P., Chaudhari, U., Lawson, F., & Turpie, A. G. G. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108898 · Cited by 531
Self-citationKhorana, A. A., Dalal, M., Lin, J., & Connolly, G. C. (2013) · Cancer · doi:10.1002/cncr.27772 · Cited by 480
Self-citationMeta-Analysis: Low-Molecular-Weight Heparin and Bleeding in Patients with Severe Renal Insufficiency
Lim, W., Dentali, F., Eikelboom, J. W., & Crowther, M. A. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-9-200605020-00011 · Cited by 443
Effects of race and ethnicity on the incidence of venous thromboembolism
White, R. H., & Keenan, C. R. (2009) · Thrombosis Research · doi:10.1016/s0049-3848(09)70136-7 · Cited by 407
Hull, R. D., Schellong, S. M., Tapson, V. F., Monreal, M., Samama, M.-M., Nicol, P., Vicaut, E., Turpie, A. G. G., Yusen, R. D., & study*, F. T. E. (. P. F. V. T. I. A. I. M. P. W. P. I. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-1-201007060-00004 · Cited by 384
Laporte-Simitsidis, S., Tardy, B., Cucherat, M., Buchmüller, A., Juillard-Delsart, D., Decousus, H., & Mismetti, P. (2000) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613749 · Cited by 373
Cronin-Fenton, D. P., Søndergaard, F., Pedersen, L. A., Fryzek, J. P., Cetin, K., Acquavella, J., Baron, J. A., & Sørensen, H. T. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605883 · Cited by 372
Palumbo, A., Cavo, M., Bringhen, S., Zamagni, E., Romano, A., Patriarca, F., Rossi, D., Gentilini, F., Crippa, C., Galli, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6844 · Cited by 323
Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer
Maraveyas, A., Waters, J., Roy, R., Fyfe, D., Propper, D., Lofts, F., Sgouros, J., Gardiner, E., Wedgwood, K., Ettelaie, C., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.10.017 · Cited by 316
Plasma tissue factor may be predictive of venous thromboembolism in pancreatic cancer
KHORANA, A. A., FRANCIS, C. W., MENZIES, K. E., WANG, J.-G., HYRIEN, O., HATHCOCK, J., MACKMAN, N., & TAUBMAN, M. B. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03156.x · Cited by 309
Self-citationLarocca, A., Cavallo, F., Bringhen, S., Di Raimondo, F., Falanga, A., Evangelista, A., Cavalli, M., Stanevsky, A., Corradini, P., Pezzatti, S., et al. (2012) · Blood · doi:10.1182/blood-2011-03-344333 · Cited by 288
Self-citationTHALER, J., AY, C., MACKMAN, N., BERTINA, R. M., KAIDER, A., MAROSI, C., KEY, N. S., BARCEL, D. A., SCHEITHAUER, W., KORNEK, G., et al. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04754.x · Cited by 274
Self-citationOutcomes and Cost of Deep Venous Thrombosis Among Patients With Cancer
Elting, L. S., Escalante, C. P., Cooksley, C., Avritscher, E. B. C., Kurtin, D., Hamblin, L., Khosla, S. G., & Rivera, E. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.15.1653 · Cited by 269
den Exter, P. L., Hooijer, J., Dekkers, O. M., & Huisman, M. V. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.34.0984 · Cited by 264
PERRY, J. R., JULIAN, J. A., LAPERRIERE, N. J., GEERTS, W., AGNELLI, G., ROGERS, L. R., MALKIN, M. G., SAWAYA, R., BAKER, R., FALANGA, A., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03973.x · Cited by 249
Self-citationSeng, S., Liu, Z., Chiu, S. K., Proverbs-Singh, T., Sonpavde, G., Choueiri, T. K., Tsao, C.-K., Yu, M., Hahn, N. M., Oh, W. K., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.4358 · Cited by 246
CARRIER, M., LE GAL, G., CHO, R., TIERNEY, S., RODGER, M., & LEE, A. Y. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03326.x · Cited by 229
Self-citationBergqvist, D., Burmark, U. S., Flordal, P. A., Frisell, J., Hallböökr, T., Hedberg, M., Horn, A., Kelty, E., Kvitting, P., Lindhagen, A., et al. (1995) · Journal of British Surgery · doi:10.1002/bjs.1800820421 · Cited by 218
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis
Dentali, F., Ageno, W., Becattini, C., Galli, L., Gianni, M., Riva, N., Imberti, D., Squizzato, A., Venco, A., & Agnelli, G. (2010) · Thrombosis Research · doi:10.1016/j.thromres.2010.03.016 · Cited by 218
Kuderer, N. M., Khorana, A. A., Lyman, G. H., & Francis, C. W. (2007) · Cancer · doi:10.1002/cncr.22892 · Cited by 212
Self-citationRisk factors for venous thromboembolic events in cancer patients
Kröger, K., Weiland, D., Ose, C., Neumann, N., Weiss, S., Hirsch, C., Urbanski, K., Seeber, S., & Scheulen, M. E. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj068 · Cited by 212
LEVINE, M. N., GU, C., LIEBMAN, H. A., ESCALANTE, C. P., SOLYMOSS, S., DEITCHMAN, D., RAMIREZ, L., & JULIAN, J. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04693.x · Cited by 190
Self-citationReduction of Mortality in General Medical In-patients by Low-Dose Heparin Prophylaxis
HALKIN, H., GOLDBERG, J., MODAN, M., & MODAN, B. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-5-561 · Cited by 187
Haas, S. K., Freund, M., Heigener, D., Heilmann, L., Kemkes-Matthes, B., Tempelhoff, G.-F. V., Melzer, N., & Kakkar, A. K. (2012) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029611433769 · Cited by 180
Self-citationIncidence and treatment of peripheral venous thrombosis in patients with glioma
Ruff, R. L., & Posner, J. B. (1983) · Annals of Neurology · doi:10.1002/ana.410130320 · Cited by 170
Complications of therapy for venous thromboembolic disease in patients with brain tumors
Levin, J. M., Schiff, D., Loeffler, J. S., Fine, H. A., Black, P. M., & Wen, P. Y. (1993) · Neurology · doi:10.1212/wnl.43.6.1111 · Cited by 161
O'Connell, C. L., Razavi, P., Ghalichi, M., Boyle, S., VASAN, S., Mark, L., Caton, A. M., Duddalwar, V. A., Boswell, W. D., Grabow, K., et al. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.04114.x · Cited by 145
Self-citationLiu, C., Yang, M., Chiang, S.-C., Hsu, H., Hong, Y., Hsiao, L., Liu, H., Chiou, T.-J., Chen, P., Lee, T., et al. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-01-0010 · Cited by 113
Venous thromboembolism prevention in gynecologic cancer surgery: A systematic review
Einstein, M. H., Pritts, E. A., & Hartenbach, E. M. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.03.004 · Cited by 107
Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients
Kanaan, A. O., Silva, M. A., Donovan, J. L., Roy, T., & Al‐Homsi, A. S. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.11.015 · Cited by 102
Noble, S., Nelson, A., Turner, C., & Finlay, I. G. (2006) · BMJ · doi:10.1136/bmj.38733.616065.802 · Cited by 101
Simonneau, G., Laporte, S., Mismetti, P., Derlon, A. B., Samii, K., Samama, C. M., & Bergman, J. F. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02083.x · Cited by 100
Mandalà, M., Barni, S., Prins, M. H., Labianca, R., Tondini, C. A., Russo, L., Milesi, A., Cremonesi, M., Zaccanelli, M., Regonesi, C., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp354 · Cited by 99
Self-citationLeonardi, M. J., McGory, M. L., & Ko, C. Y. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9183-9 · Cited by 93
Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center
Shinagare, A. B., Guo, M., Hatabu, H., Krajewski, K. M., Andriole, K. P., den Abbeele, A. D. V., DiPiro, P. J., & Nishino, M. (2011) · Cancer · doi:10.1002/cncr.25941 · Cited by 91
Barginear, M. F., Gralla, R. J., Bradley, T. P., Ali, S. S., Shapira, I., Greben, C. R., Nier-Shoulson, N. J., Akerman, M. B., LESSER, M. L., & Budman, D. R. (2012) · Supportive Care in Cancer · doi:10.1007/s00520-012-1413-z · Cited by 91
Heit, J. A., Beckman, M. G., Bockenstedt, P. L., Grant, A. M., Key, N. S., Kulkarni, R., Manco‐Johnson, M. J., Moll, S., Ortel, T. L., & Philipp, C. S. (2010) · American Journal of Hematology · doi:10.1002/ajh.21735 · Cited by 86
Self-citationAkl, E. A. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.12.1261 · Cited by 82
Riess, H. B., Pelzer, U., Hilbig, A., Stieler, J., Opitz, B., Scholten, T., Kauschat-Brüning, D., Bramlage, P., Dörken, B., & Oettle, H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-361 · Cited by 81
Rieß, H., Pelzer, U., Opitz, B., Stauch, M. B., Reitzig, P., Hahnfeld, S., Müller, L., Stieler, J., Dörken, B., & Oettle, H. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.15_suppl.4033 · Cited by 76
Knowledge of Venous Thromboembolism (VTE) prevention among hospitalized patients
Sage, S. L., McGee, M., & Emed, J. D. (2008) · Journal of Vascular Nursing · doi:10.1016/j.jvn.2008.09.005 · Cited by 70
Rates of venous thromboembolism occurrence in medical patients among the insured population
Hussein, M. A., Lin, J., Battleman, D. S., & Spyropoulos, A. C. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-02-0073 · Cited by 69
Verso, M., Gussoni, G., & Agnelli, G. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03901.x · Cited by 64
Prevention of Venous Thromboembolism in Hospitalized Patients With Cancer
Francis, C. W. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.3644 · Cited by 60
Self-citationRiess, H. B., Haas, S. K., Tebbe, U., Gerlach, H.-E., Abletshauser, C., Sieder, C., Rossol, S., Pfeiffer, B., & Schellong, S. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03848.x · Cited by 58
High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients
Singh, R. K., Sousou, T., Mohile, S. G., & Khorana, A. A. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03929.x · Cited by 57
Self-citationLeizorovicz, A., Siguret, V., & Mottier, D. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.03.002 · Cited by 55
Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma
Wun, T., & White, R. H. R. (2010) · Thrombosis Research · doi:10.1016/s0049-3848(10)70024-4 · Cited by 47
Cancer Patients and Awareness of Venous Thromboembolism
Sousou, T., & Khorana, A. A. (2009) · Cancer Investigation · doi:10.3109/07357900902744544 · Cited by 42
Self-citationRisk assessment for cancer-associated thrombosis: What is the best approach?
Khorana, A. A. (2012) · Thrombosis Research · doi:10.1016/s0049-3848(12)70009-9 · Cited by 39
Self-citationIs Incidentally Detected Pulmonary Embolism in Cancer Patients Less Severe? A Case-Control Study
Palla, A., Rossi, G., Falaschi, F., Marconi, L., Pistolesi, M., & Prandoni, P. (2011) · Cancer Investigation · doi:10.3109/07357907.2011.633295 · Cited by 32
Romera-Villegas, A., Cairols-Castellote, M. A., Vila-Coll, R., Martí-Mestre, X., Colomé, E., & Iguaz, I. (2009) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2009.08.006 · Cited by 31
The management of venous thromboembolism in cancer patients
Dolan, S., & Fitch, M. I. (2007) · British Journal of Nursing · doi:10.12968/bjon.2007.16.21.27715 · Cited by 27
Cited by
Brahmer, J. R., Lacchetti, C., Schneider, B. J., Atkins, M. B., Brassil, K. J., Caterino, J. M., Chau, I., Ernstoff, M. S., Gardner, J. M., Ginex, P., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6385 · Cited by 3,713
Key, N. S., Khorana, A. A., Kuderer, N. M., Bohlke, K., Lee, A. Y. Y., Arcelus, J. I., Wong, S. L., Balaban, E. P., Flowers, C. R., Francis, C. W., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01461 · Cited by 1,504
Self-citationLyman, G. H., Bohlke, K., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7351 · Cited by 1,371
Self-citationYoung, A. M., Marshall, A., Thirlwall, J., Chapman, O., Lokare, A., Hill, C., Hale, D., Dunn, J. A., Lyman, G. H., Hutchinson, C., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2018.78.8034 · Cited by 1,348
Self-citationLyman, G. H., Carrier, M., Ay, C., Di Nisio, M., Hicks, L. K., Khorana, A. A., Leavitt, A. D., Lee, A. Y. Y., Macbeth, F., Morgan, R. L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020003442 · Cited by 893
Self-citation
Metadata
- Authors
- Lyman, G. H., Khorana, A. A., Kuderer, N. M., Lee, A. Y., Arcelus, J. I., Balaban, E. P., Clarke, J. M., Flowers, C. R., Francis, C. W., Gates, L. E., Kakkar, A. K., Key, N. S., Levine, M. N., Liebman, H. A., Tempero, M. A., Wong, S. L., Prestrud, A. A., & Falanga, A.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-06-10
- Volume
- 31
- Issue
- 17
- Pages
- 2189-2204
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W4247355438
- Cited by
- 713
- References
- 75
- FWCI
- 91.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.